🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Farshid Dayyani

University of California, Irvine

ORCID: 0000-0002-4970-5189
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study”.

First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.028
N/A
0.604DataRank · unranked
55 citations

Tanios Bekaii‐Saab, Patrick M. Boland, Farshid Dayyani, Teresa Macarulla, Kabir Mody +8 more

A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma

Clinical Colorectal Cancer(2023)10.1016/j.clcc.2023.11.001
N/A
0.119DataRank · unranked
1 citations

Jasmine Balangue, Jennifer Valerin, Matthew Keating, Jason A. Zell, Thomas H. Taylor +2 more

Predictors of outcomes in patients with gastric cancer treated with contemporary multimodality strategies—a single institution experience

Journal of Gastrointestinal Oncology(2020)10.21037/jgo.2019.01.08
N/A
0DataRank · unranked
1 citations

Michelle Park, Darryl T. Hiyama, Farshid Dayyani, Tuyen Hoang

Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol

Clinical Colorectal Cancer(2021)10.1016/j.clcc.2021.11.004
N/A
0DataRank · unranked
5 citations

Joseph C. Carmichael, Farshid Dayyani, Chelsea McKinney, Lari Wenzel, Jason A. Zell +2 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136
N/A
0DataRank · unranked
12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

A phase 2 single-arm study of berzosertib in combination with irinotecan in patients with progressive TP53 mutant gastric and gastro-esophageal junction cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4044
N/A
0DataRank · unranked
4 citations

Heloisa P. Soares, Farshid Dayyani, Anwaar Saeed, Edward S. Kim, Ning Jin +7 more

A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in metastatic colorectal adenocarcinoma

Research Square(2023)10.21203/rs.3.rs-2739109/v1
N/A
0DataRank · unranked
0 citations

Jasmine Balangue, Jennifer Valerin, Matthew Keating, Jason A. Zell, Thomas H. Taylor +2 more

Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2023.7333
N/A
0DataRank · unranked
7 citations

Naomie Devico Marciano, Deepika Nathan, Wen‐Pin Chen, Christine E. McLaren, Kathryn Osann +7 more

Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors

The Oncologist(2025)10.1093/oncolo/oyaf169
N/A
0DataRank · unranked
4 citations

Farshid Dayyani, David Sommerhalder, Andrae Lavon Vandross, Meredith S. Pelster, Jason T. Henry +9 more

Gene mutations distinguishing gastric from colorectal and esophageal adenocarcinomas

Journal of Gastrointestinal Oncology(2020)10.21037/jgo.2019.12.06
N/A
0DataRank · unranked
3 citations

Anand K. Ganesan, Darryl T. Hiyama, Farshid Dayyani, Tuyen Hoang

NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer

The Oncologist(2025)10.1093/oncolo/oyaf400
N/A
0DataRank · unranked
0 citations

Shannon Stockton, Heloisa P. Soares, Farshid Dayyani, Anwaar Saeed, Edward Kim +12 more

Variability in multimodality treatment influences survival in non- metastatic gastric cancer patients

Journal of Gastrointestinal Oncology(2020)10.21037/jgo-20-212
N/A
0DataRank · unranked
1 citations

Farshid Dayyani, Ariceli A. Alfaro, Jasmine Huynh, Jingran Ji, Andrew H. Ko +3 more